{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T18:02:22Z","timestamp":1780423342238,"version":"3.54.1"},"reference-count":81,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J NeuroIntervent Surg"],"accepted":{"date-parts":[[2026,5,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Meningiomas are typically managed with surgery or radiotherapy, but recurrent or surgically inaccessible tumors present a persistent therapeutic gap, particularly for progressive higher grade disease. Intra-arterial yttrium-90 (90Y) transarterial radioembolization (TARE) is well established for hepatocellular carcinoma to deliver high dose, short range \u03b2-brachytherapy in the form of 20-60\u00b5m radioactive microspheres. This technology could plausibly be adapted to meningiomas, exploiting their dominant dural arterial supply.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed systematic searches of PubMed and Google Scholar for literature directly addressing intracranial TARE planning or delivery, supplemented by a scoping review of adjacent fields: meningioma radionuclide therapy, peptide receptor radionuclide therapy (PRRT), hepatic TARE, bland meningioma embolization, and the radiobiology relevant to meningioma vascular behavior, dosimetry, hypoxia, and imaging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five studies and one ongoing clinical trial directly addressed intracranial TARE or its planning. Seventy-four supporting studies informed synthesis across meningioma embolization, vascular anatomy, hepatic TARE dosimetry and device characteristics, and foundational radiobiology. Currently two TARE platforms exist (glass and resin), with differences in dose-per sphere and physical density which may impact deliverability. The compartmentalized dural arterial supply of most meningiomas supports catheter-based access and may permit single-compartment dosimetry modeling, with generally low-to-moderate arterial shunting risk. The established but incomplete efficacy of radioligand therapies provides a biologic rationale for TARE, while underscoring the need for higher tumor radiation delivery, which early dosimetry work suggests may be achievable with TARE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TARE is a plausible treatment for recurrent and inoperable meningiomas due to their compartmentalized vascular supply. Four considerations should anchor early phase trial design: (1) microsphere platform selection between glass and resin spheres, with their differing embolic burden and dosimetric profiles; (2) whether to limit treatment to external carotid artery territories or include internal carotid artery supplied tumor; (3) compartmental dosimetric planning calibrated to meningioma angiosomes; and (4) a structured safety framework non-target deposition, peri-procedural risks, and delayed radiation necrosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnis-2026-025330","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:20:32Z","timestamp":1780420832000},"page":"jnis-2026-025330","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Yttrium-90 Radioembolization for Recurrent Meningioma: Rationale and Roadmap for Neurointerventional Translation"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4987-5815","authenticated-orcid":false,"given":"Aaron Daniel","family":"Brake","sequence":"first","affiliation":[{"name":"Department of Radiology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"John","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchay","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University of Iowa Health Care, Iowa City, Iowa, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett","family":"Green","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Renown Health, Reno, Nevada, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan H","family":"Siddiqui","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University at Buffalo, Buffalo, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riad","family":"Salem","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Northwestern University, Evanston, Illinois, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Sarwar","sequence":"additional","affiliation":[{"name":"Division of Interventional Radiology, Department of Radiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5130-1378","authenticated-orcid":false,"given":"David","family":"Altschul","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Montefiore Einstein Medical Center, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3408-1297","authenticated-orcid":false,"given":"Santiago","family":"Ortega-Gutierrez","sequence":"additional","affiliation":[{"name":"Neuroloy, Neurosurgery and Radiology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Laroia","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, University of Iowa Health Care, Iowa City, Iowa, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Zanaty","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Iowa Health Care, Iowa City, Iowa, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"2026060210201552000_jnis-2026-025330v1.1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noab150"},{"key":"2026060210201552000_jnis-2026-025330v1.2","first-page":"i67","article-title":"Radiotherapy and radiosurgery for meningiomas","volume":"5","author":"Chen","year":"2023","journal-title":"Neurooncol Adv"},{"key":"2026060210201552000_jnis-2026-025330v1.3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11060-022-04171-9","article-title":"Radiotherapy for meningiomas","volume":"160","author":"Chen","year":"2022","journal-title":"J Neurooncol"},{"key":"2026060210201552000_jnis-2026-025330v1.4","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-200012000-00008"},{"key":"2026060210201552000_jnis-2026-025330v1.5","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A3919"},{"key":"2026060210201552000_jnis-2026-025330v1.6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1055\/s-0040-1720954","article-title":"Yttrium-90 Radioembolization Dosimetry: What Trainees Need to Know","volume":"37","author":"Villalobos","year":"2020","journal-title":"Semin Intervent Radiol"},{"key":"2026060210201552000_jnis-2026-025330v1.7","doi-asserted-by":"crossref","DOI":"10.1186\/s13550-020-00679-1","article-title":"Yttrium-90 radioembolization as a possible new treatment for brain cancer: proof of concept and safety analysis in a canine model","volume":"10","author":"Pasciak","year":"2020","journal-title":"EJNMMI Res"},{"key":"2026060210201552000_jnis-2026-025330v1.8","first-page":"1679","article-title":"Arteriovenous shunt measurement during endovascular therapy for cerebrospinal lesions","volume":"18","author":"Mariani","year":"1997","journal-title":"AJNR Am J Neuroradiol"},{"key":"2026060210201552000_jnis-2026-025330v1.9","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/j.radcr.2020.07.051","article-title":"Mapping angiography and transarterial technetium macroaggregated albumin particle simulation of recurrent atypical intracranial meningioma: feasibility for potential vascular brachytherapy","volume":"15","author":"Toskich","year":"2020","journal-title":"Radiol Case Rep"},{"key":"2026060210201552000_jnis-2026-025330v1.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.115.155853"},{"key":"2026060210201552000_jnis-2026-025330v1.11","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-009-1115-z"},{"key":"2026060210201552000_jnis-2026-025330v1.12","unstructured":"Intra-arterial yttrium-90 microsphere therapy for recurrent glioblastoma (frontier). nct05303467 . 2026. Available: https:\/\/clinicaltrials.gov\/study\/NCT05303467"},{"key":"2026060210201552000_jnis-2026-025330v1.13","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.147256"},{"key":"2026060210201552000_jnis-2026-025330v1.14","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/now060"},{"key":"2026060210201552000_jnis-2026-025330v1.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-024-06783-x"},{"key":"2026060210201552000_jnis-2026-025330v1.16","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1093\/neuonc\/noae069","article-title":"Radioligand therapies in meningioma: Evidence and future directions","volume":"26","author":"Mair","year":"2024","journal-title":"Neuro Oncol"},{"key":"2026060210201552000_jnis-2026-025330v1.17","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1093\/neuonc\/noae200","article-title":"Do we need dosimetry for the optimization of theranostics in CNS tumors?","volume":"26","author":"Cicone","year":"2024","journal-title":"Neuro Oncol"},{"key":"2026060210201552000_jnis-2026-025330v1.18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.23736\/S1824-4785.24.03571-4","article-title":"177Lu-labeled somatostatin receptor targeted radionuclide therapy dosimetry in meningioma: a systematic review","volume":"68","author":"Boursier","year":"2024","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"2026060210201552000_jnis-2026-025330v1.19","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00259-022-06044-9","article-title":"Efficacy and safety of peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma","volume":"50","author":"Minczeles","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026060210201552000_jnis-2026-025330v1.20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s00259-025-07336-6","article-title":"SSTR-directed peptide receptor radionuclide therapy for recurrent meningiomas: analysis of safety, efficacy and prognostic factors","volume":"53","author":"Hasenauer","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026060210201552000_jnis-2026-025330v1.21","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.249607"},{"key":"2026060210201552000_jnis-2026-025330v1.22","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.266956"},{"key":"2026060210201552000_jnis-2026-025330v1.23","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17122039","article-title":"Peptide Receptor Radionuclide Therapy in Patients with Advanced, Recurrent or Progressive Meningioma: An Updated Systematic Review and Meta-Analysis","volume":"17","author":"Muoio","year":"2025","journal-title":"Cancers (Basel)"},{"key":"2026060210201552000_jnis-2026-025330v1.24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1055\/a-0802-5039","article-title":"Intraindividual comparison of selective intraarterial versus systemic intravenous 68Ga-DOTATATE PET\/CT in patients with inoperable meningioma","volume":"58","author":"Verburg","year":"2019","journal-title":"Nuklearmedizin"},{"key":"2026060210201552000_jnis-2026-025330v1.25","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262491"},{"key":"2026060210201552000_jnis-2026-025330v1.26","doi-asserted-by":"crossref","DOI":"10.1007\/s11060-025-05266-9","article-title":"Efficacy of Intra-arterial [177Lu]Lu-DOTATATE monotherapy for treatment-refractory meningioma","volume":"176","author":"El Ghalbouni","year":"2025","journal-title":"J Neurooncol"},{"key":"2026060210201552000_jnis-2026-025330v1.27","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s00270-019-02262-1","article-title":"Will 177Lu-DOTATATE Treatment Become More Effective in Salvage Meningioma Patients, When Boosting Somatostatin Receptor Saturation? A Promising Case on Intra-arterial Administration","volume":"42","author":"Braat","year":"2019","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2026060210201552000_jnis-2026-025330v1.28","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4103\/NI.Neurol-India-D-23-00252","article-title":"PRRT with Lu-177 DOTATATE in Treatment-Refractory Progressive Meningioma: Initial Experience from a Tertiary-Care Neuro-Oncology Center","volume":"72","author":"Puranik","year":"2024","journal-title":"Neurol India"},{"key":"2026060210201552000_jnis-2026-025330v1.29","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.268217"},{"key":"2026060210201552000_jnis-2026-025330v1.30","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jvir.2015.02.022","article-title":"Selective internal radiation therapy: quantifying distal penetration and distribution of resin and glass microspheres in a surrogate arterial model","volume":"26","author":"Jernigan","year":"2015","journal-title":"J Vasc Interv Radiol"},{"key":"2026060210201552000_jnis-2026-025330v1.31","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31819"},{"key":"2026060210201552000_jnis-2026-025330v1.32","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2014.00198","article-title":"Side effects of yttrium-90 radioembolization","volume":"4","author":"Riaz","year":"2014","journal-title":"Front Oncol"},{"key":"2026060210201552000_jnis-2026-025330v1.33","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20150943","article-title":"Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry","volume":"89","author":"Tong","year":"2016","journal-title":"Br J Radiol"},{"key":"2026060210201552000_jnis-2026-025330v1.34","doi-asserted-by":"crossref","DOI":"10.1186\/s13550-025-01343-2","article-title":"Single-center experience comparing glass and resin microspheres in lobar Y-90 SIRT for early- to intermediate-stage hepatocellular carcinoma","volume":"15","author":"Zheng","year":"2025","journal-title":"EJNMMI Res"},{"key":"2026060210201552000_jnis-2026-025330v1.35","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.acra.2020.04.012","article-title":"Yttrium-90 Radioembolization and Tumor Hypoxia: Gas-challenge BOLD Imaging in the VX2 Rabbit Model of Hepatocellular Carcinoma","volume":"28","author":"Gordon","year":"2021","journal-title":"Acad Radiol"},{"key":"2026060210201552000_jnis-2026-025330v1.36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jvir.2013.10.030","article-title":"Pilot study of angiogenic response to yttrium-90 radioembolization with resin microspheres","volume":"25","author":"Carpizo","year":"2014","journal-title":"J Vasc Interv Radiol"},{"key":"2026060210201552000_jnis-2026-025330v1.37","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1433480","article-title":"Arterial hypoperfusion as a negative predictive marker for primary hepatic malignancies treated with Y-90 glass microsphere transarterial radioembolization","volume":"14","author":"Kalaghchi","year":"2024","journal-title":"Front Oncol"},{"key":"2026060210201552000_jnis-2026-025330v1.38","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00270-024-03933-4","article-title":"Hepatocellular Carcinoma with Vascular Invasion Treated with Resin Yttrium-90 Transarterial Radioembolization Using Single Compartment Dosimetry","volume":"48","author":"Tahir","year":"2025","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2026060210201552000_jnis-2026-025330v1.39","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.3390\/ph17081057","article-title":"Hypoxia as a Target for Combination with Transarterial Chemoembolization in Hepatocellular Carcinoma","volume":"17","author":"Wang","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"key":"2026060210201552000_jnis-2026-025330v1.40","doi-asserted-by":"crossref","unstructured":"Brake A , Fry L , Young CC , et al . Definitive embolization of meningiomas: a 20-year updated systematic review. J Neurointerv Surg 2026:jnis-2025-024837. doi:10.1136\/jnis-2025-024837","DOI":"10.1136\/jnis-2025-024837"},{"key":"2026060210201552000_jnis-2026-025330v1.41","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.wneu.2022.05.002","article-title":"Efficacy and Outcome of Embolization of Intracranial Meningiomas With Minimal Resources","volume":"167","author":"Sarma","year":"2022","journal-title":"World Neurosurg"},{"key":"2026060210201552000_jnis-2026-025330v1.42","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-003-1005-1"},{"key":"2026060210201552000_jnis-2026-025330v1.43","first-page":"666","article-title":"MR imaging- and MR spectroscopy-revealed changes in meningiomas for which embolization was performed without subsequent surgery","volume":"21","author":"Bendszus","year":"2000","journal-title":"AJNR Am J Neuroradiol"},{"key":"2026060210201552000_jnis-2026-025330v1.44","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.wneu.2017.06.047","article-title":"Long-Term Volume Reduction Effects of Endovascular Embolization for Intracranial Meningioma: Preliminary Experience of 5 Cases","volume":"105","author":"Nakajima","year":"2017","journal-title":"World Neurosurg"},{"key":"2026060210201552000_jnis-2026-025330v1.45","doi-asserted-by":"crossref","DOI":"10.3171\/2018.1.FOCUS17686","article-title":"Preoperative embolization of skull base meningiomas: current indications, techniques, and pearls for complication avoidance","volume":"44","author":"Yoon","year":"2018","journal-title":"Neurosurg Focus"},{"key":"2026060210201552000_jnis-2026-025330v1.46","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2176\/jns-nmc.2025-0081","article-title":"Real-world Experience of Embolization for Intracranial Tumors in Japan: Analysis of 2,756 Cases from Japanese Registry of NeuroEndovascular Therapy 4","volume":"65","author":"Haruma","year":"2025","journal-title":"Neurol Med Chir(Tokyo)"},{"key":"2026060210201552000_jnis-2026-025330v1.47","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A1754"},{"key":"2026060210201552000_jnis-2026-025330v1.48","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/jbm.a.34334","article-title":"Fractal dimension and Shannon\u2019s entropy analyses of the architectural complexity caused by the inflammatory reactions induced by highly crystalline poly(vinyl alcohol) microspheres implanted in subcutaneous tissues of the Wistar rats","volume":"101A","author":"Silva","year":"2013","journal-title":"J Biomedical Materials Res"},{"key":"2026060210201552000_jnis-2026-025330v1.49","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1148\/radiol.2020201895","article-title":"Nonspherical Polyvinyl Alcohol Particles versus Tris-Acryl Microspheres: Randomized Controlled Trial Comparing Pain after Uterine Artery Embolization for Symptomatic Fibroids","volume":"298","author":"Han","year":"2021","journal-title":"Radiology"},{"key":"2026060210201552000_jnis-2026-025330v1.50","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jvir.2016.07.001","article-title":"Impact of Yttrium-90 Microsphere Density, Flow Dynamics, and Administration Technique on Spatial Distribution: Analysis Using an In Vitro Model","volume":"28","author":"Caine","year":"2017","journal-title":"J Vasc Interv Radiol"},{"key":"2026060210201552000_jnis-2026-025330v1.51","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2023.2226366","article-title":"Transarterial radioembolization: a systematic review on gaining control over the parameters that influence microsphere distribution","volume":"30","author":"Snoeijink","year":"2023","journal-title":"Drug Deliv"},{"key":"2026060210201552000_jnis-2026-025330v1.52","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26133966","article-title":"Microspheres Used in Liver Radioembolization: From Conception to Clinical Effects","volume":"26","author":"d\u2019Abadie","year":"2021","journal-title":"Molecules"},{"key":"2026060210201552000_jnis-2026-025330v1.53","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1007\/s00259-021-05600-z","article-title":"EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds","volume":"49","author":"Weber","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026060210201552000_jnis-2026-025330v1.54","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.14157","article-title":"AAPM Medical Physics Practice Guideline 14.a: Yttrium-90 microsphere radioembolization","volume":"25","author":"Busse","year":"2024","journal-title":"J Appl Clin Med Phys"},{"key":"2026060210201552000_jnis-2026-025330v1.55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.wneu.2021.04.065","article-title":"Cone-Beam Computed Tomography Fusion Technique for Vascular Assessment of Skull Base Meningiomas","volume":"151","author":"Yoshida","year":"2021","journal-title":"World Neurosurg"},{"key":"2026060210201552000_jnis-2026-025330v1.56","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1016\/j.wneu.2018.08.078","article-title":"Longitudinal Imaging of Tumor Volume, Diffusivity, and Perfusion After Preoperative Endovascular Embolization in Supratentorial Hemispheric Meningiomas","volume":"120","author":"Gruber","year":"2018","journal-title":"World Neurosurg"},{"key":"2026060210201552000_jnis-2026-025330v1.57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215145","article-title":"Non-invasive qualitative and semiquantitative presurgical investigation of the feeding vasculature to intracranial meningiomas using superselective arterial spin labeling","volume":"14","author":"Jensen-Kondering","year":"2019","journal-title":"PLoS One"},{"key":"2026060210201552000_jnis-2026-025330v1.58","doi-asserted-by":"crossref","DOI":"10.1177\/20584601221091208","article-title":"MRI multiparametric scoring system for pial blood supply of intracranial meningiomas","volume":"11","author":"Higaki","year":"2022","journal-title":"Acta Radiol Open"},{"key":"2026060210201552000_jnis-2026-025330v1.59","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.2214\/AJR.18.21026","article-title":"Arterial Spin-Labeling MRI Identifies Hypervascular Meningiomas","volume":"213","author":"Mayercik","year":"2019","journal-title":"AJR Am J Roentgenol"},{"key":"2026060210201552000_jnis-2026-025330v1.60","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1118\/1.3615164","article-title":"3D modeling of effects of increased oxygenation and activity concentration in tumors treated with radionuclides and antiangiogenic drugs","volume":"38","author":"Lagerl\u00f6f","year":"2011","journal-title":"Med Phys"},{"key":"2026060210201552000_jnis-2026-025330v1.61","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990215)85:4<936::AID-CNCR23>3.0.CO;2-J"},{"key":"2026060210201552000_jnis-2026-025330v1.62","doi-asserted-by":"publisher","DOI":"10.1215\/S1152851704001115"},{"key":"2026060210201552000_jnis-2026-025330v1.63","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1320243111"},{"key":"2026060210201552000_jnis-2026-025330v1.64","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11060-014-1503-5","article-title":"Hypoxia inducible factor-1 is involved in growth factor, glucocorticoid and hypoxia mediated regulation of vascular endothelial growth factor-A in human meningiomas","volume":"119","author":"Wu","year":"2014","journal-title":"J Neurooncol"},{"key":"2026060210201552000_jnis-2026-025330v1.65","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11060-013-1208-1","article-title":"Evaluation of mast cells and hypoxia inducible factor-1 expression in meningiomas of various grades in correlation with peritumoral brain edema","volume":"115","author":"Reszec","year":"2013","journal-title":"J Neurooncol"},{"key":"2026060210201552000_jnis-2026-025330v1.66","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1377"},{"key":"2026060210201552000_jnis-2026-025330v1.67","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1682352","article-title":"Expression of GLUT3 and HIF-1\u03b1 in Meningiomas of Various Grades Correlated with Peritumoral Brain Edema","volume":"2020","author":"Mei","year":"2020","journal-title":"Biomed Res Int"},{"key":"2026060210201552000_jnis-2026-025330v1.68","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3857\/roj.2016.02012","article-title":"Tumor hypoxia and reoxygenation: the yin and yang for radiotherapy","volume":"34","author":"Hong","year":"2016","journal-title":"Radiat Oncol J"},{"key":"2026060210201552000_jnis-2026-025330v1.69","doi-asserted-by":"crossref","first-page":"i90","DOI":"10.1093\/jrr\/rrw007","article-title":"The impact of hypoxia and its modification of the outcome of radiotherapy","volume":"57 Suppl 1","author":"Horsman","year":"2016","journal-title":"J Radiat Res"},{"key":"2026060210201552000_jnis-2026-025330v1.70","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-014-9531-7"},{"key":"2026060210201552000_jnis-2026-025330v1.71","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2017.10.005"},{"key":"2026060210201552000_jnis-2026-025330v1.72","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20130686","article-title":"Vasculogenesis: a crucial player in the resistance of solid tumours to radiotherapy","volume":"87","author":"Brown","year":"2014","journal-title":"Br J Radiol"},{"key":"2026060210201552000_jnis-2026-025330v1.73","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1259\/0007-1285-26-312-638","article-title":"The Concentration of Oxygen Dissolved in Tissues at the Time of Irradiation as a Factor in Radiotherapy","volume":"26","author":"Gray","year":"1953","journal-title":"BJR"},{"key":"2026060210201552000_jnis-2026-025330v1.74","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14794","article-title":"Microglia in radiation\u2010induced brain injury: Cellular and molecular mechanisms and therapeutic potential","volume":"30","author":"Wang","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"2026060210201552000_jnis-2026-025330v1.75","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/jnen\/nlz091","article-title":"Distinct Expression Patterns of Carbonic Anhydrase IX in Clear Cell, Microcystic, and Angiomatous Meningiomas","volume":"78","author":"Chkheidze","year":"2019","journal-title":"J Neuropathol Exp Neurol"},{"key":"2026060210201552000_jnis-2026-025330v1.76","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2002.97.3.0658"},{"key":"2026060210201552000_jnis-2026-025330v1.77","doi-asserted-by":"publisher","DOI":"10.1227\/NEU.0b013e3182567886"},{"key":"2026060210201552000_jnis-2026-025330v1.78","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10735-020-09940-2","article-title":"Influence of VEGF-A, VEGFR-1-3, and neuropilin 1-2 on progression-free: and overall survival in WHO grade II and III meningioma patients","volume":"52","author":"Bernatz","year":"2021","journal-title":"J Mol Histol"},{"key":"2026060210201552000_jnis-2026-025330v1.79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217340","article-title":"Systemic management of malignant meningiomas: A comparative survival and molecular marker analysis between Octreotide in combination with Everolimus and Sunitinib","volume":"14","author":"Cardona","year":"2019","journal-title":"PLoS One"},{"key":"2026060210201552000_jnis-2026-025330v1.80","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.jvir.2024.06.023","article-title":"Imageable Radioembolization Microspheres for Treatment of Unresectable Hepatocellular Carcinoma: Interim Results from a First-in-Human Trial","volume":"35","author":"Abraham","year":"2024","journal-title":"J Vasc Interv Radiol"},{"key":"2026060210201552000_jnis-2026-025330v1.81","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"}],"container-title":["Journal of NeuroInterventional Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnis-2026-025330","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:20:41Z","timestamp":1780420841000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnis.bmj.com\/lookup\/doi\/10.1136\/jnis-2026-025330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":81,"alternative-id":["10.1136\/jnis-2026-025330"],"URL":"https:\/\/doi.org\/10.1136\/jnis-2026-025330","relation":{},"ISSN":["1759-8478","1759-8486"],"issn-type":[{"value":"1759-8478","type":"print"},{"value":"1759-8486","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]}}}